Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY – Get Free Report) hit a new 52-week low during trading on Thursday . The company traded as low as $6.59 and last traded at $6.6380, with a volume of 58717 shares trading hands. The stock had previously closed at $6.85.
Wall Street Analyst Weigh In
Separately, Sanford C. Bernstein raised Coloplast A/S to a “hold” rating in a research report on Wednesday, January 28th. Three research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock has an average rating of “Hold”.
Check Out Our Latest Stock Report on CLPBY
Coloplast A/S Stock Down 1.3%
Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) last announced its earnings results on Friday, February 6th. The company reported $0.10 earnings per share for the quarter, beating the consensus estimate of $0.09 by $0.01. The firm had revenue of $1.11 billion during the quarter, compared to the consensus estimate of $1.12 billion. Coloplast A/S had a return on equity of 27.87% and a net margin of 14.35%. On average, analysts predict that Coloplast A/S Sponsored ADR will post 0.31 earnings per share for the current year.
About Coloplast A/S
Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.
In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.
Further Reading
Receive News & Ratings for Coloplast A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coloplast A/S and related companies with MarketBeat.com's FREE daily email newsletter.
